PARP1/BRD4-IN-2 is a potent and selective inhibitor of PARP1 and BRD4 (IC50 = 197 nM and 238 nM, respectively); it inhibits DNA damage repair, blocks G0/G1 cell cycle progression, induces apoptosis, and exhibits antitumor activity in the MDA-MB-468 mouse xenograft tumor model; it can be used for the research of triple-negative breast cancer (TNBC).